Hypomethylation of Alu repetitive elements in esophageal mucosa, and its potential contribution to the epigenetic field for cancerization

Cancer Causes and Control

Volumn 23, Issue 6, 2012, Pages 865-873

  Matsuda, Yasunori ^a,b   Yamashita, Satoshi ^a   Lee, Yi Chia ^c   Niwa, Tohru ^a   Yoshida, Takeichi ^a   Gyobu, Ken ^a   Igaki, Hiroyasu ^d   Kushima, Ryoji ^d   Lee, Shigeru ^b   Wu, Ming Shiang ^c   Osugi, Harushi ^b   Suehiro, Shigefumi ^b   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cancer testis antigen; Epigenetics; Esophageal squamous cell carcinoma; Hypomethylation; Repetitive element

Indexed keywords

NY ESO 1 ANTIGEN;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINE1 GENE; MAGE C1 GENE; MAJOR CLINICAL STUDY; MALE; NY ESO 1 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RISK FACTOR; TUMOR GENE;

ALU ELEMENTS; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; EPIGENOMICS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PROMOTER REGIONS, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 84862502196     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9955-4     Document Type: Article

References (36)

1. Shibata A, Matsuda T, Ajiki W, Sobue T (2008) Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001. Jpn J Clin Oncol 38:464-468
2. Lu CL, Lang HC, Luo JC, Liu CC, Lin HC, Chang FY, Lee SD (2009) Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control 21:269-274
3. Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24:729-735
4. Pesko P, Rakic S, Milicevic M, Bulajic P, Gerzic Z (1994) Prevalence and clinicopathologic features of multiple squamous cell carcinoma of the esophagus. Cancer 73:2687-2690 (Pubitemid 24166251)
5. Shimizu Y, Tukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M (2001) Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resection. Gastrointest Endosc 54:190-194
6. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-968
7. Ushijima T (2007) Epigenetic field for cancerization. J Biochem Mol Biol 40:142-150
8. Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T (2009) The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 115:3412-3426
9. Lee YC, Wang HP, Wang CP, Ko JY, Lee JM, Chiu HM, Lin JT, Yamashita S, Oka D, Watanabe N et al (2011) Revisit of field cancerization in squamous cell carcinoma of upper aero digestive tract: better risk assessment with epigenetic markers. Cancer Prev Res 4:1982-1992
10. Xing EP, Nie Y, Song Y, Yang GY, Cai YC, Wang LD, Yang CS (1999) Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 5:2704-2713 (Pubitemid 29493943)
11. Si HX, Tsao SW, Lam KY, Srivastava G, Liu Y, Wong YC, Shen ZY, Cheung AL (2001) E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett 173:71-78 (Pubitemid 32907511)
12. Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K (1998) Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 58:3429-3434 (Pubitemid 28371086)
13. Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC et al (2006) Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol 28:767-773
14. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92 (Pubitemid 13154475)
15. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128:683-692 (Pubitemid 46273572)
16. Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21:5400-5413
17. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93:7149-7153 (Pubitemid 26243517)
18. Kaneda A, Tsukamoto T, Takamura-Enya T, Watanabe N, Kaminishi M, Sugimura T, Tatematsu M, Ushijima T (2004) Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 95:58-64 (Pubitemid 38208408)
19. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32:e38
20. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33:6823-6836 (Pubitemid 41830488)
21. Caballero OL, Chen YT (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100:2014-2021
22. Gnjatic S, Nishikawa H, Jungbluth AA, Gure AO, Ritter G, Jager E, Knuth A, Chen YT, Old LJ (2006) NY-ESO-1: review of an immunogenic tumor antigen. Adv Cancer Res 95:1-30 (Pubitemid 44088423)
23. Nuber N, Curioni-Fontecedro A, Matter C, Soldini D, Tiercy JM, von Boehmer L, Moch H, Dummer R, Knuth A, van den Broek M (2010) Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patients. Proc Natl Acad Sci USA 107:15187-15192
24. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395:89-93 (Pubitemid 28420236)
25. Eden A, Gaudet F, Waghmare A, Jaenisch R (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455 (Pubitemid 36444319)
26. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300:489-492 (Pubitemid 36444330)
27. Kaneda A, Kaminishi M, Sugimura T, Ushijima T (2004) Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett 212:203-210 (Pubitemid 38997976)
28. Yoshida T, Yamashita S, Takamura-Enya T, Niwa T, Ando T, Enomoto S, Maekita T, Nakazawa K, Tatematsu M, Ichinose M et al (2011) Alu and Satalpha hypomethylation in Helicobacter pylori-infected gastric mucosae. Int J Cancer 128:33-39
29. Wilson AS, Power BE, Molloy PL (2007) DNA hypomethylation and human diseases. Biochim Biophys Acta 1775:138-162 (Pubitemid 44881198)
30. Kim BH, Cho NY, Shin SH, Kwon HJ, Jang JJ, Kang GH (2009) CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma. Virchows Arch 455:343-351
31. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734-1738
32. Dewannieux M, Esnault C, Heidmann T (2003) LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35:41-48 (Pubitemid 37048594)
33. Belancio VP, Hedges DJ, Deininger P (2008) Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res 18:343-358 (Pubitemid 351347078)
34. Bourc'his D, Bestor TH (2004) Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431:96-99
35. Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP et al (2006) De novo induction of a cancer/testis antigen by 5-aza-20-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res 66:1105-1113 (Pubitemid 43165979)
36. Oi S, Natsume A, Ito M, Kondo Y, Shimato S, Maeda Y, Saito K, Wakabayashi T (2009) Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-20-deoxycytidine in glioma cells. J Neurooncol 92:15-22